MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-25-0004420
Aet Laboratories Private Limited - pharma in Sangareddy, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹246.84 Cr
▲ 15% YoY
Net profit · FY 2025
₹21.05 Cr
Net margin 8.5%
EBITDA · FY 2025
₹38.56 Cr
EBITDA margin 15.6%
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹8.18 Cr
Issued & subscribed
Open charges
₹24.21 Lakh
Secured borrowings
Company age
23 yrs
Est. 2003
Employees · EPFO
304
Provident fund records
About Aet Laboratories Private Limited
Data last updated:
Aet Laboratories Private Limited is a private limited company based in Sangareddy, Telangana, India, a subsidiary of Alfred E. Tiefenbacher (Gmbh & Co.Kg). It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 September 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2003PTC041756. Its GSTIN is 36AADCM6591L1ZX (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹8.18 Cr. It was formerly known as Medikon Galenicals Limited and Medikon Galenicals Private Limited. It is led by directors including Swapnil Singh (Managing Director) and Oliver Robert Alexander Schrader.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Survey No.42 Gaddapotharam Kazipally Industrial Area, Sangareddy, Telangana, India – 502319.
As per the financials filed for FY 2025, the company reported a revenue of ₹246.84 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹21.05 Cr (net margin 8.5%) and EBITDA of ₹38.56 Cr (EBITDA margin 15.6%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 19% over five years.
The company has about 304 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹24.21 Lakh on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 1 case is pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹2.51 Cr; the latest was in April 2008. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Abaris Healthcare Private Limited with revenue of ₹257.73 Cr. The company has 2 MSME Form 1 returns on record between 2023 and 2024, listing 134 overdue payments to 5 micro and small suppliers.
Aet Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-25-0004420). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aet.eu.
Company details
CIN U24239TG2003PTC041756
Registration Number 041756
Incorporation Date 24 September 2003
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Alfred E. Tiefenbacher (Gmbh & Co.Kg)
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-25-0004420
Name history
Aet Laboratories has undergone 3 name changes throughout its history. The company was previously known as Medikon Galenicals Limited, Medikon Galenicals Private Limited, and Aet Laboratories Limited. The current legal name is Aet Laboratories Private Limited.
| Company Name | Status |
|---|---|
| Aet Laboratories Private Limited | Current |
| Medikon Galenicals Limited | Previous |
| Medikon Galenicals Private Limited | Previous |
| Aet Laboratories Limited | Previous |
CIN history
Aet Laboratories has one previous CIN (Corporate Identification Number): U24239AP2003PTC041756. The current CIN is U24239TG2003PTC041756, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2003PTC041756 | Current |
| U24239AP2003PTC041756 | Previous |
Key People
Swapnil Singh Managing Director Oliver Robert Alexander Schrader Director Kristian Philip Ruepp Director Recognitions & Rankings of Aet Laboratories
Contact details
Aet Laboratories Private Limited's registered office is in Sangareddy, Telangana. Its website is aet.eu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSurvey No.42 Gaddapotharam Kazipally Industrial Area, Sangareddy, Telangana, India – 502319
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aet Laboratories Private Limited, buy the company report.
Comprehensive company report
Aet Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Aet Laboratories are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Aet Laboratories Private Limited, buy the company report.
Financials of Aet Laboratories Private Limited
FY 2024 filings availableAet Laboratories Private Limited reported revenue of ₹246.84 Cr (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹246.84 Cr ▲ 15%
Net profit · FY 2025
₹21.05 Cr margin 8.5%
EBITDA · FY 2025
₹38.56 Cr margin 15.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 4%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▼ 5%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 15% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹38.56 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹21.05 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.6% | ||||
| Net Profit Margin | 8.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aet Laboratories Private Limited, buy the company report.
Board of directors of Aet Laboratories Private Limited
Aet Laboratories has 6 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapnil Singh Also directs: Aet Clinical Services Private Limited | Managing Director | 30 Sep 2022 | 4 Years 0 Months | Current |
| Oliver Robert Alexander Schrader Also directs: Aet Clinical Services Private Limited | Director | 06 Mar 2019 | 7 Years 7 Months | Current |
| Kristian Philip Ruepp | Director | 06 Mar 2019 | 7 Years 7 Months | Current |
| Dieter Schoenfeld | Director | 21 Jan 2004 | 22 Years 9 Months | Current |
| Dr Georg Stark Also directs: Assurgen Pharma Private Limited | Director | 01 Sep 2015 | 11 Years 1 Months | Current |
| Sandip Kacharu Tarate | Additional Director | 29 Aug 2025 | 1 Years 1 Months | Current |
Peer comparison
Aet Laboratories Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Abaris Healthcare Private Limited | ₹257.73 Cr (FY 2025) | 5.0% | New Delhi, Delhi, India | |||
| Pretty Petals Private Limited | ₹251.52 Cr (FY 2025) | 21.0% | New Delhi, Delhi, India | |||
| East India Pharmaceutical Works Limited | ₹249.94 Cr (FY 2024) | Kolkata, West Bengal, India | ||||
| Aet Laboratories Private Limitedthis company | ₹246.84 Cr (FY 2025) | ₹21.05 Cr | 8.5% | 15.0% | 304 | Sangareddy, Telangana, India |
| Icpa Health Products Ltd | ₹246.81 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Vivek Pharmachem (India) Limited | ₹245.53 Cr (FY 2025) | -8.0% | Jaipur, Rajasthan, India | |||
| Blue Circle Organics Private Limited | ₹243.24 Cr (FY 2019) | 35.0% | Mumbai, Maharashtra, India | |||
| Khandelwal Laboratories Private Limited | ₹240.41 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Aet Laboratories Private Limited, buy the company report.
Auditor
Aet Laboratories Private Limited is audited by GPHK & Associates for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GPHK & Associates | FY 2022 | 008053S |
Shareholding
The shareholding of Aet Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aet Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹24.21 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Nov 2022 | 100628699 | The Hongkong and Shanghai Banking Corporation Limited | ₹10 Lakh | Open | |
| 26 Apr 2021 | 100450668 | Hdfc Bank Limited | ₹7.07 Lakh | Open | |
| 16 Apr 2021 | 100448385 | Hdfc Bank Limited | ₹7.14 Lakh | Open |
Total charge records: 3 View all charges
Deals & funding
Aet Laboratories Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹2.51 Cr; the latest was in April 2008.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹2.51 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2008 | Funding round | ₹2.51 Cr | Investors: Alfred E Tiefenbacher (GmbH & Co. KG) |
| May 2007 | Secondary share transfer | Undisclosed | Buyer: Alfred E Tiefenbacher (GmbH & Co. KG) Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Aet Laboratories Private Limited has 3 court cases on record: 2 filed by Aet Laboratories, 1 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed by the company
2
Filed against the company
1
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 1 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Helsinn Healthcare Sa | Pending |
| High Court of Delhi | Court case (FAO(OS) (COMM)) | Filed by the company against Helsinn Healthcare Sa | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against Central Power Distribution Company of Andhra Pradesh and 2 others | Disposed |
To see the full case history of Aet Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Aet Laboratories Private Limited has 2 MSME Form 1 returns on record between 2023 and 2024, listing 134 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 5)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Bharat Science Apparatas Workshop | |||
| Vasco Scientifics Private Limited | |||
| an individual supplier | |||
| Silicon Integrated Technologies | |||
| Chrome Source |
To see the full MSME payment records of Aet Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Aet Laboratories has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Aet Clinical Services Private Limited | U74999TG2015PTC097155 |
To see the full group structure of Aet Laboratories Private Limited, buy the company report.
Employees & EPFO
Aet Laboratories Private Limited has a workforce of 304 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
304
Active EPFO establishments
1
Employee growth
4.83%
GST
Aet Laboratories has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AADCM6591L1ZX | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aet Laboratories Private Limited, buy the company report.
Recent activity
Aet Laboratories Private Limited has 15 board changes on record since 2004: 6 appointments and 9 cessations. The latest: Sandip Kacharu Tarate was appointed as Additional Director on 29 Aug 2025.
Appointed
Sandip Kacharu Tarate was appointed as Additional Director.
AGM
Aet Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Aet Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with The Hongkong And Shanghai Banking Corporation Limited amounted to Rs. 0.10 Cr with Charge ID 100628699 was registered on 11 Nov 2022.
Ceased
Kirankumar Subbaraja Madallapalli ceased to be Director.
Appointed
Swapnil Singh was appointed as Managing Director.
Ceased
Swapnil Singh ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.07 Cr with Charge ID 100450668 was registered on 26 Apr 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.07 Cr with Charge ID 100448385 was registered on 16 Apr 2021.
Ceased
Balaramesha Chary Rallabandi ceased to be Managing Director.
Ceased
Srinivasa Rao Battula ceased to be Managing Director.
Ceased
Kristian Philip Ruepp ceased to be Additional Director.
9 earlier events are in the company report.
Frequently asked questions
Aet Laboratories is an active private limited company based in Sangareddy, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 September 2003 (23+ years old) and is registered under CIN U24239TG2003PTC041756.
Aet Laboratories has 6 current directors:
- Swapnil Singh - Managing Director
- Oliver Robert Alexander Schrader - Director
- Kristian Philip Ruepp - Director
- Dieter Schoenfeld - Director
- Dr Georg Stark - Director
- Sandip Kacharu Tarate - Additional Director
The latest financial statements of Aet Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Aet Laboratories is 36AADCM6591L1ZX, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Aet Laboratories is U24239TG2003PTC041756. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aet Laboratories has 3 court cases on record: 2 filed by the company and 1 filed against it. 1 is pending.
Aet Laboratories was incorporated on 24 September 2003, making it 23+ years old. It is registered with the Registrar of Companies, Hyderabad.
Aet Laboratories has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹2.51 Cr; the latest was in April 2008.
The peers of Aet Laboratories by revenue are Abaris Healthcare Private Limited, Pretty Petals Private Limited, East India Pharmaceutical Works Limited, Icpa Health Products Ltd, Vivek Pharmachem (India) Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sandip Kacharu Tarate was appointed as Additional Director on 29 Aug 2025. Kirankumar Subbaraja Madallapalli ceased to be Director on 17 Oct 2022. Swapnil Singh was appointed as Managing Director on 30 Sep 2022. Aet Laboratories has 15 board changes on record in total.
Yes, Aet Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-25-0004420).
Aet Laboratories has 2 MSME Form 1 returns on record between 2023 and 2024, listing 134 overdue payments to 5 micro and small suppliers. The latest return was filed on 18 Apr 2024.